Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,547,530 | 2,627,410 | 3,171,800 | 3,869,760 | 4,376,006 |
| Marketable Securities | N/A | N/A | N/A | 665,251 | 2,241,962 |
| Receivables | 865,080 | 676,278 | 358,027 | 173,168 | 483,113 |
| Inventories | 608,227 | 494,986 | 416,122 | 282,346 | 242,626 |
| TOTAL | $6,233,589 | $3,991,593 | $4,203,414 | $5,207,078 | $7,613,880 |
| Non-Current Assets | |||||
| PPE Net | 1,641,678 | 1,578,423 | 1,324,154 | 845,946 | 587,605 |
| Intangibles | 62,704 | 51,095 | 57,138 | 40,616 | 46,679 |
| Other Non-Current Assets | 250,602 | 299,799 | 220,569 | 285,650 | 287,361 |
| TOTAL | $1,954,984 | $1,929,317 | $1,601,861 | $1,172,212 | $921,645 |
| Total Assets | $8,188,573 | $5,920,910 | $5,805,275 | $6,379,290 | $8,535,525 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 328,969 | N/A |
| Accounts payable and accrued liabilities | 479,035 | 404,997 | 315,111 | 294,781 | 262,400 |
| Accrued Expenses | 1,109,120 | 803,713 | 693,731 | 467,352 | 558,055 |
| Other current liabilities | 121,059 | 111,154 | 68,004 | 114,335 | 120,801 |
| TOTAL | $1,828,830 | $2,214,899 | $1,810,113 | $1,468,528 | $1,599,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 961,913 | 166,484 | 197,618 | 209,148 | 202,113 |
| Deferred Revenues | N/A | N/A | N/A | 213,861 | 187,414 |
| Other Non-Current Liabilities | 983,427 | 165,298 | 243,723 | 260,237 | 366,836 |
| TOTAL | $1,998,549 | $373,789 | $457,835 | $527,407 | $803,407 |
| Total Liabilities | $3,827,379 | $2,588,688 | $2,267,948 | $1,995,935 | $2,402,962 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,943 | 106,721 | 104,578 | 104,319 | 102,677 |
| Common Shares | 144 | 138 | 135 | 135 | 133 |
| Retained earnings | -8,319,903 | -8,606,836 | -7,962,050 | -7,080,342 | -5,076,527 |
| Other shareholders' equity | -78,187 | -148,990 | -99,448 | -77,418 | 17,947 |
| TOTAL | $4,361,194 | $3,332,222 | $3,537,327 | $4,383,355 | $6,132,563 |
| Total Liabilities And Equity | $8,188,573 | $5,920,910 | $5,805,275 | $6,379,290 | $8,535,525 |